H. Orskov

发表

The pathogenesis of diabetic angiopathy and growth hormone.

T. Olsen, K. Lundbaek, N. Christensen, 1971, Danish medical bulletin.

Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients.

H. Orskov, N. Møller, J. Jørgensen, 2011, The Journal of clinical endocrinology and metabolism.

Effect of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans.

M. Walker, K. Alberti, H. Orskov, 1991, The American journal of physiology.

Increased myocardial contractility during intravenous insulin infusion in type 1 (insulin-dependent) diabetic patients: an echocardiographic study.

N. Christensen, H. Orskov, O. Schmitz, 1988, Scandinavian journal of clinical and laboratory investigation.

The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.

H. Orskov, N. Møller, J. Jørgensen, 2007, The Journal of clinical endocrinology and metabolism.

Diagnosis of growth hormone deficiency.

H. Orskov, M. Andersen, S. Fisker, 2005, Frontiers of hormone research.

Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.

H. Orskov, J. Frystyk, J. Jørgensen, 1997, European journal of endocrinology.

Long-term efficacy and tolerability of octreotide treatment in acromegaly.

A. Harris, H. Orskov, J. Jørgensen, 1992, Metabolism: clinical and experimental.

Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: The Oxford Regional Prospective Study

D. Dunger, D. Matthews, H. Orskov, 2005, Clinical endocrinology.

Octreotide and diabetes: theoretical and experimental aspects.

A. Harris, H. Orskov, J. Frystyk, 1992, Metabolism: clinical and experimental.

Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique.

K. Alberti, H. Orskov, J. Jørgensen, 1989, The Journal of clinical endocrinology and metabolism.

In vivo insulin action in type 1 (insulin-dependent) diabetic pregnant women as assessed by the insulin clamp technique.

H. Orskov, H. Beck-Nielsen, K. Hermansen, 1985, The Journal of clinical endocrinology and metabolism.

Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man

K. Alberti, H. Orskov, L. Monti, 2004, Acta Diabetologica.

Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects.

K. Alberti, N. Porksen, H. Orskov, 1994, Metabolism: clinical and experimental.

Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: effect of nonesterified fatty acids.

M. Walker, K. Alberti, H. Orskov, 1993, Metabolism: clinical and experimental.

The independent effect of ketone bodies on forearm glucose metabolism in normal man.

M. Walker, K. Alberti, H. Orskov, 1991, Scandinavian journal of clinical and laboratory investigation.

Effects of a growth hormone pulse on total and forearm substrate fluxes in humans.

K. Alberti, H. Orskov, N. Møller, 1990, The American journal of physiology.

Metabolic effects of cortisol in man--studies with somatostatin.

K. Alberti, D. Johnston, H. Orskov, 1982, Metabolism: clinical and experimental.

The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.

K. Johansen, H. Orskov, 1972, Acta endocrinologica.

Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.

K. Alberti, N. Christensen, H. Orskov, 1985, Metabolism: clinical and experimental.

The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man.

K. Alberti, H. Orskov, L. Monti, 1993, Diabetes research and clinical practice.

The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitus.

K. Alberti, H. Orskov, C. Hales, 1992, The Journal of clinical endocrinology and metabolism.

Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.

H. Orskov, J. Veldhuis, J. Christiansen, 1997, The American journal of physiology.

Free insulin-like growth factors in human obesity.

H. Orskov, J. Frystyk, C. Mogensen, 1995, Metabolism: clinical and experimental.

Calorigenic effects of growth hormone: the role of thyroid hormones.

H. Orskov, N. Møller, J. Jørgensen, 1996, The Journal of clinical endocrinology and metabolism.

Metabolic effects of growth hormone in humans.

H. Orskov, N. Møller, J. Christiansen, 1995, Metabolism: clinical and experimental.

Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects.

K. Alberti, H. Orskov, N. Møller, 1993, The Journal of clinical endocrinology and metabolism.

Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.

K. Alberti, H. Orskov, N. Møller, 1990, The Journal of clinical endocrinology and metabolism.

Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.

H. Orskov, P. Sönksen, R. Baxter, 1999, The Journal of clinical endocrinology and metabolism.

Dose-response characteristics of human proinsulin and insulin in non-insulin-dependent diabetic humans.

K. Alberti, H. Orskov, L. Monti, 1992, The American journal of physiology.

Metabolic effects of the use of protein-sparing infusions in postoperative patients.

K. Alberti, H. Orskov, C. Binder, 1980, Clinical science.

Inhibition of insulin secretion by somatostatin.

K. Alberti, K. Lundbaek, N. Christensen, 1973, Lancet.

No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.

M. Kjaer, H. Orskov, R. Dall, 2001, The Journal of clinical endocrinology and metabolism.

Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.

H. Orskov, E. Dupont, S. E. Christensen, 1984, Advances in neurology.

Growth hormone in uremia. I. Plasma growth hormone, insulin and glucagon after oral and intravenous glucose in uremic subjects.

N. Christensen, H. Orskov, 1971, Scandinavian journal of clinical and laboratory investigation.

Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.

K. Alberti, D. Johnston, H. Orskov, 1983, Clinical science.

Effect of lanreotide, a somatostatin analogue, on urea synthesis in normal man.

H. Orskov, T. Wolthers, T. Grøfte, 1994, Clinical nutrition.

Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.

K. Lundbaek, A. P. Hansen, H. Orskov, 1978, Metabolism: clinical and experimental.

Somatostatin: a tool for investigation of the metabolic effects of cortisol and glucagon.

K. Alberti, D. Johnston, H. Orskov, 1978, Metabolism: clinical and experimental.

The Role of Plasma Non‐esterified Fatty Acids During Exercise in Type 2 Diabetes Mellitus

J. W. Reed, K. Alberti, H. Orskov, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Hyperglucagonaemia in cirrhosis

H. Orskov, S. Sherlock, G. Smith-Laing, 1980, Diabetologia.

Relationship to HepatoceHular Damage

H. Orskov, S. Sherlock, G. Smith-Laing, 1980 .

Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study.

H. Orskov, J. Frystyk, J. Jørgensen, 1995, European journal of endocrinology.

Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.

K. Alberti, H. Orskov, H. Beck-Nielsen, 1985, Diabetes research.

Insulin resistance in uraemic insulin-dependent diabetics. Effect of dialysis therapy as assessed by the artificial endocrine pancreas.

K. Alberti, H. Orskov, O. Schmitz, 1984, Acta endocrinologica.

A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance.

R. Heine, K. Alberti, H. Orskov, 1985, Diabetes research.

Greater in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and somatostatin secretory pulses.

R. Turner, D. Matthews, H. Orskov, 1987, Endocrinology.

Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.

H. Orskov, J. Jørgensen, J. Christiansen, 1997, Metabolism: clinical and experimental.

Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.

K. Alberti, H. Orskov, J. Parsons, 1983, The American journal of physiology.

Wick chromatography for the immunoassay of serum thyrotropin.

H. Orskov, J. Weeke, 1973, The Journal of laboratory and clinical medicine.

Physiological levels of plasma non-esterified fatty acids impair forearm glucose uptake in normal man.

M. Walker, K. Alberti, H. Orskov, 1990, Clinical science.

Metabolic abnormalities in children of non-insulin dependent diabetics.

K. Alberti, H. Orskov, I. Hanning, 1986, British medical journal.

The relationship between endogenous serum insulin concentration and glucose uptake in the forearm muscles of nondiabetics.

N. Christensen, H. Orskov, 1968, The Journal of clinical investigation.

Diabetes, diabetic angiopathy, and growth hormone.

T. Olsen, K. Lundbaek, N. Christensen, 1970, Lancet.

The origin of cerebrospinal fluid somatostatin: hypothalamic or disperse central nervous system secretion?

A. P. Hansen, H. Orskov, S. E. Christensen, 1981, Neuroendocrinology.

Ultrasensitive radioimmunoassay for direct determination of free triiodothyronine concentration in serum.

H. Orskov, J. Weeke, 1975, Scandinavian journal of clinical and laboratory investigation.

A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?

H. Orskov, L. Thuesen, P. Henningsen, 2009, Acta medica Scandinavica.

Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories.

N. Skakkebaek, H. Orskov, A. Andersson, 1995, European journal of endocrinology.

Hormonal and Metabolic Changes in Hepatic Cirrhosis

K. Alberti, D. Johnston, H. Orskov, 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.

K. Alberti, H. Orskov, K. Hermansen, 1988, Metabolism: clinical and experimental.

Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.

N. Skakkebaek, H. Orskov, A. Juul, 2000, The Journal of clinical endocrinology and metabolism.

Renal hypertrophy in experimental diabetes.

H. Orskov, R. Osterby, A. Flyvbjerg, 1991, The Journal of diabetic complications.

Fuel metabolism in growth hormone-deficient adults.

H. Orskov, N. Møller, J. Jørgensen, 1995, Metabolism: clinical and experimental.

Significance of glucose load in oral glucose tolerance tests. Blood glucose, serum insulin, growth hormone and free fatty acids.

N. Christensen, A. P. Hansen, H. Orskov, 2009, Acta medica Scandinavica.

Metabolic interactions of glucagon and cortisol in man--studies with somatostatin.

K. Alberti, D. Johnston, H. Orskov, 1982, Metabolism: clinical and experimental.

Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.

H. Orskov, R. Osterby, J. Frystyk, 1992, The American journal of physiology.

Measurement of and Correction for Incubation Damage in Radioimmunoassay

H. Orskov, K. Seyer-Hansen, 1974, European journal of clinical investigation.

Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.

H. Orskov, J. Frystyk, B. Dinesen, 1995, Growth regulation.

Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.

H. Orskov, J. Clausen, K. Højlund, 2005, The Journal of clinical endocrinology and metabolism.

Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment.

I. Lancranjan, H. Orskov, P. Marbach, 2000, European journal of endocrinology.

Glucose uptake and pulsatile insulin infusion: euglycaemic clamp and [3-3H]glucose studies in healthy subjects.

H. Orskov, H. Beck-Nielsen, O. Schmitz, 1986, Acta endocrinologica.

Ketosis resistance in fibrocalculous pancreatic diabetes: II. Hepatic ketogenesis after oral medium-chain triglycerides.

K. Alberti, H. Orskov, C. Yajnik, 1997, Metabolism: clinical and experimental.

Low-dose intravenous glucagon has no effect on myocardial contractility in normal man. An echocardiographic study.

H. Orskov, J. Christiansen, L. Thuesen, 1988, Scandinavian journal of clinical and laboratory investigation.

Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study.

H. Orskov, J. Christiansen, L. Thuesen, 1988, Danish medical bulletin.

Letter: Somatostatin and insulinoma.

K. Lundbaek, A. P. Hansen, H. Orskov, 1968, Lancet.

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.

H. Orskov, J. Frystyk, N. Møller, 2003, Circulation.

Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients.

A. Harris, H. Orskov, J. Christiansen, 1993, Acta endocrinologica.

Hormonal regulation of ketone-body metabolism in man.

K. Alberti, D. Johnston, H. Orskov, 1978, Biochemical Society symposium.

Vibratory perception during ischaemia in uraemic patients and in subjects with mild carbohydrate intolerance.

N. Christensen, H. Orskov, 1969, Journal of neurology, neurosurgery, and psychiatry.

Angiotensin-converting enzyme in diabetes mellitus dependence on metabolic aberration.

K. Alberti, Á. Hreidarsson, H. Orskov, 1983, Diabete & metabolisme.

Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release.

K. Lundbaek, A. P. Hansen, H. Orskov, 1974, Scandinavian journal of clinical and laboratory investigation.

Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans.

K. Alberti, D. Johnston, H. Orskov, 1986, The American journal of medicine.

The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.

H. Orskov, J. Frystyk, T. Grøfte, 1997, The Journal of clinical endocrinology and metabolism.

Characterization of somatostatin release from the pancreas: the role of potassium.

H. Orskov, K. Hermansen, S. E. Christensen, 1979, Scandinavian journal of clinical and laboratory investigation.

Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults.

H. Orskov, J. Jørgensen, J. Christiansen, 1997, The Journal of clinical endocrinology and metabolism.

Insulin-like growth factor-I, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X.

H. Bøtker, H. Orskov, O. Schmitz, 1997, American Journal of Cardiology.

Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats.

H. Orskov, R. Baxter, J. Frystyk, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Acetate: inhibitor of growth hormone hypersecretion in diabetic and non-diabetic uraemic subjects.

H. E. Hansen, K. Alberti, A. P. Hansen, 1982, Acta endocrinologica.

Effect of graded renal ablation on kidney and serum insulin-like growth factor-I (IGF-I) and IGF binding proteins in rats: relation to compensatory renal growth.

H. Orskov, A. Flyvbjerg, B. Nielsen, 1997, Metabolism: clinical and experimental.

Cardiovascular disease and insulin-like growth factor I.

H. Orskov, J. Frystyk, N. Møller, 2002, Circulation.

Kidney lesions in rats with severe long term alloxan diabetes. 3. Glomerular ultrastructure.

T. Olsen, K. Lundbaek, H. Orskov, 1967, Laboratory investigation; a journal of technical methods and pathology.

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients.

I. Lancranjan, H. Orskov, S. Lamberts, 1996, Metabolism: clinical and experimental.

Body temperature elevation, exercise and serum prolactin concentrations.

H. Orskov, J. Møller, S. E. Christensen, 1985, Acta endocrinologica.

Characterization of growth hormone release in response to external heating. Comparison to exercise induced release.

H. Orskov, S. E. Christensen, N. Møller, 1984, Acta endocrinologica.

Insulin-induced choleresis in relation to insulin concentrations in plasma and bile in the cat.

H. Orskov, O. Thomsen, J. A. Larsen, 1982, Scandinavian journal of gastroenterology.

Effects of heparin on renal morphology and albuminuria in experimental diabetes.

H. Orskov, R. Osterby, J. Frystyk, 1996, The American journal of physiology.

Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline.

H. Orskov, J. Frystyk, O. Schmitz, 1997, The American journal of physiology.

Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.

H. Orskov, H. Emanuelsson, O. Amtorp, 1995, American heart journal.

Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques.

K. Alberti, H. Orskov, L. Monti, 1993, Diabetes research.

Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.

P. Vestergaard, H. Orskov, L. Mosekilde, 1999, The Journal of clinical endocrinology and metabolism.

Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay.

H. Orskov, J. Weeke, 1973, Scandinavian journal of clinical and laboratory investigation.

Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.

H. Orskov, J. Frystyk, H. Grønbaek, 1995, The Journal of endocrinology.

Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.

A. Harris, H. Orskov, J. Frystyk, 1992, Kidney international.

Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats.

H. Orskov, R. Osterby, H. Grønbaek, 1997, The American journal of physiology.

Very early changes in circulating T3 and rT3 during development of metabolic derangement in diabetic patients.

L. Regeur, P. Laurberg, H. Orskov, 2009, Acta medica Scandinavica.

Impaired growth hormone secretion and increased growth hormone-binding protein levels in subfertile males.

H. Orskov, J. Christiansen, K. Ho, 1996, Fertility and sterility.

Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses.

H. Orskov, N. Møller, J. Jørgensen, 1992, Fertility and sterility.

A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.

H. Orskov, J. Frystyk, J. Christiansen, 2003, American journal of physiology. Endocrinology and metabolism.

Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.

H. Orskov, A. Flyvbjerg, S. Madsbad, 2004, Metabolism: clinical and experimental.

Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.

H. Orskov, J. Frystyk, A. Flyvbjerg, 1999, Kidney international.

Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.

H. Orskov, A. Flyvbjerg, S. Marshall, 1991, The American journal of physiology.

Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.

H. Orskov, K. Højlund, H. Beck-Nielsen, 2005, The Journal of clinical endocrinology and metabolism.

Release of somatostatin-like immunoreactivity from the perfused canine thyroid. Selective stimulatory effect of calcium ions.

P. Laurberg, H. Orskov, 1981, The Journal of clinical investigation.

Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.

K. Alberti, H. Orskov, A. Flyvbjerg, 1988, The Journal of clinical endocrinology and metabolism.

Immunological measurements of urinary insulin for the evaluation of insulin production.

K. Johansen, H. Orskov, 1972, Acta endocrinologica.

Influence of growth hormone binding protein on growth hormone estimation in different immunoassays.

H. Orskov, S. Fisker, L. Ebdrup, 1998, Scandinavian journal of clinical and laboratory investigation.

No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis.

H. Orskov, A. Flyvbjerg, C. Skjærbæk, 1998, The Journal of clinical endocrinology and metabolism.

Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hyperthyroid rats.

H. Orskov, N. Møller, J. Jørgensen, 1997, Journal of hepatology.

Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.

H. Orskov, J. Jørgensen, J. Christiansen, 1999, European journal of endocrinology.

Effect of growth hormone on the inflammatory activity of experimental colitis in rats.

S. Laurberg, H. Orskov, A. Flyvbjerg, 1993, Scandinavian journal of gastroenterology.

Diabetes-like alterations in hemostatic parameters after growth hormone administration for one week in normal man.

H. Orskov, N. Møller, J. Christiansen, 1989, The Journal of diabetic complications.

Effects of growth hormone and thyroxine on kidney insulin-like growth factor-I and renal growth in hypophysectomized rats.

H. Orskov, A. Flyvbjerg, S. Marshall, 1993, The Journal of endocrinology.

Serum-insulin in remission of juvenile diabetes.

K. Johansen, H. Orskov, 1968, Lancet.

Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.

H. Orskov, J. Jørgensen, J. Christiansen, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The Significance of the Na+/K+ Pump for Somatostatin Release

H. Orskov, K. Hermansen, H. Ørskov, 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.

H. Orskov, R. Baxter, J. Frystyk, 1998, Endocrinology.

Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats.

H. Orskov, H. Grønbaek, A. Flyvbjerg, 1998, Metabolism: clinical and experimental.

Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.

I. Lancranjan, H. Orskov, R. Osterby, 1998, Kidney international.

Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone and insulin-like growth factor I.

H. Orskov, A. Flyvbjerg, M. Everts, 1991, Metabolism: clinical and experimental.

Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes.

H. Orskov, A. Flyvbjerg, 1990, Acta endocrinologica.

Growth hormone restores normal growth in selenium-treated rats without increase in circulating somatomedin C.

H. Orskov, A. Flyvbjerg, H. Ørskov, 1988, Acta endocrinologica.

Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients.

H. Orskov, A. Flyvbjerg, J. Christiansen, 1988, Acta endocrinologica.

Effect of intravenous glucagon infusion on renal haemodynamics and renal tubular handling of sodium in healthy humans.

H. Orskov, H. Eiskjaer, S. Schwartz Sørensen, 1993, Scandinavian journal of clinical and laboratory investigation.

Effect of growth hormone on steroidogenesis, insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells.

H. Orskov, P. Ovesen, H. J. Ingerslev, 1994, The Journal of endocrinology.

Somatostatin-stimulated insulin-like growth factor binding protein-1 release is abolished by hyperinsulinemia.

H. Orskov, T. Wolthers, A. Flyvbjerg, 1994, The Journal of clinical endocrinology and metabolism.

Increased myocardial performance following acute hyperglycaemia in insulin-dependent diabetic patients. A consequence of increased peripheral blood flow?

N. Christensen, H. Orskov, O. Schmitz, 1987, Scandinavian journal of clinical and laboratory investigation.

Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.

H. Orskov, J. Frystyk, C. Gravholt, 2001, American journal of physiology. Endocrinology and metabolism.

Exposure of vascular allografts to insulin-like growth factor-I (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats.

H. Orskov, N. Motomura, P. Ramwell, 1998, Transplantation.

Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty.

H. Suryapranata, H. Orskov, J. Frystyk, 1996, Circulation.

Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.

H. Orskov, J. Frystyk, J. Jørgensen, 2000, Clinical Endocrinology.

Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide, a somatostatin analog.

H. Orskov, J. Frystyk, T. Wolthers, 1994, The Journal of clinical endocrinology and metabolism.

A randomized comparison of intranasal and injectable octreotide administration in patients with acromegaly.

A. Harris, H. Orskov, S. E. Christensen, 1992, The Journal of clinical endocrinology and metabolism.

SMS 201-995 and thyroid function in acromegaly: acute, intermediate and long-term effects.

A. Harris, H. Orskov, S. E. Christensen, 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Growth hormone treatment of subfertile males.

H. Orskov, K. Ho, J. Christiansen, 1996, Fertility and sterility.

Insulin-like growth factor I (IGF-I) and IGF binding proteins in seminal plasma before and after vasectomy in normal men.

H. Orskov, A. Flyvbjerg, P. Ovesen, 1995, Fertility and sterility.

Kidney lesions in rats with severe long-term alloxan diabetes. 2. Histochemical studies, comparison with human diabetic glomerular lesions.

T. Olsen, K. Lundbaek, H. Orskov, 1966, Acta pathologica et microbiologica Scandinavica.

Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke.

A. Tjønneland, K. Overvad, H. Sørensen, 2005, The Journal of clinical endocrinology and metabolism.

Glucose content in human skin: relationship with blood glucose levels.

H. Orskov, J. Christiansen, P. Bjerring, 1995, Scandinavian journal of clinical and laboratory investigation.

[Growth hormone treatment of men with reduced sperm quality].

H. Orskov, J. Christiansen, P. Ovesen, 1998, Ugeskrift for laeger.

Hyperkalemic periodic paralysis. Relationships between changes in plasma water, electrolytes, insulin and catecholamines during attacks.

H. Orskov, O. Kristensen, T. Clausen, 1980, Scandinavian journal of clinical and laboratory investigation.

Kinetics and secretion of placental growth hormone around parturition.

H. Orskov, N. Møller, J. Fuglsang, 2006, European journal of endocrinology.

The pharmacokinetics of free insulin-like growth factor-I in healthy subjects.

H. Orskov, J. Frystyk, E. Froesch, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.

K. Alberti, H. Orskov, C. Yajnik, 1992, Diabetes research and clinical practice.

Growth hormone and mild exercise in combination increases markedly muscle mass and tetanic tension in old rats.

N. B. Andersen, H. Orskov, H. Oxlund, 2000, European journal of endocrinology.

The diagnosis of insuloma.

K. Lundbaek, H. Orskov, H. Yde, 2009, Acta medica Scandinavica.

Cubilin is an albumin binding protein important for renal tubular albumin reabsorption.

H Birn, J. Fyfe, S. Moestrup, 2000, The Journal of clinical investigation.

Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.

H. Orskov, J. Christiansen, K. Kastrup, 1983, Acta endocrinologica.

Salbutamol inhalations suppress attacks of hyperkalemia in familial periodic paralysis.

H. Orskov, T. Clausen, P. Wang, 1978, Monographs in human genetics.

Effects of growth hormone on growth and muscle Na(+)-K+ pump concentration in K(+)-deficient rats.

H. Orskov, A. Flyvbjerg, M. Everts, 1992, The American journal of physiology.

Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.

S. Laurberg, H. Orskov, M. B. Jensen, 1998, The Journal of clinical endocrinology and metabolism.

Growth hormone and diabetic angiopathy.

T. Olsen, K. Lundbaek, N. Christensen, 1970, The Lancet.

Factors modifying growth hormone estimates in immunoassays.

H. Orskov, S. Fisker, 1996, Hormone Research.

Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.

K. Alberti, H. Orskov, N. Møller, 1995, The Journal of clinical endocrinology and metabolism.

Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study.

H. Orskov, J. Frystyk, H. Grønbaek, 1994, European journal of endocrinology.

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

H. Orskov, A. Flyvbjerg, M. Wilken, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?

H. Orskov, 1996, Metabolism: clinical and experimental.

GH stimulation tests: evaluation of GH responses to heat test versus insulin-tolerance test.

H. Orskov, J. Jørgensen, J. Christiansen, 1998, European journal of endocrinology.

Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules.

H. Orskov, S. Nielsen, A. Flyvbjerg, 1993, The American journal of physiology.

Endurance Training and its Effect upon the Activity of the GH-IGFs System in the Elderly

I. Heuser, H. Orskov, J. Frystyk, 1998, International journal of sports medicine.

Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.

H. Orskov, J. Frystyk, H. Grønbaek, 1996, Experimental nephrology.

Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.

H. Orskov, J. Frystyk, J. Christiansen, 1996, European journal of endocrinology.

Long-term experimental insulin-deficiency diabetes--a model of diabetic angiopathy?

T. Olsen, H. Orskov, K. Lundboek, 2009, Acta medica Scandinavica. Supplementum.

An inexpensive apparatus for making precise, continuous, complex gradients for column chromatography.

H. Orskov, H. J. Gundersen, J. Weeke, 1972, The Journal of laboratory and clinical medicine.

Plasma Disappearance Rate of Injected Human Insulin in Juvenile Diabetic, Maturity-onset Diabetic and Nondiabetic Subjects

N. Christensen, H. Orskov, 1969, Diabetes.

Growth in young rats after termination of sodium selenite exposure: studies of growth hormone and somatomedin C.

H. Orskov, A. Flyvbjerg, O. Thorlacius-Ussing, 1988, Toxicology.

Acute effects of graded alcohol intake on glucose, insulin and free fatty acid levels in non-insulin-dependent diabetic subjects.

H. Orskov, K. Hermansen, H. Glerup, 1993, European journal of clinical nutrition.

Ultrafiltration method for direct radioimmunoassay measurement of free thyroxine and free tri-iodothyronine in serum.

H. Orskov, J. Weeke, N. Boye, 1986, Scandinavian journal of clinical and laboratory investigation.

Diabetic angiopathy: new experimental and clinical aspects.

H. Orskov, A. Flyvbjerg, 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR).

H. Orskov, M. Montini, G. Pagani, 1997, European journal of endocrinology.

Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats.

H. Orskov, J. Frystyk, H. Grønbaek, 1995, The Journal of endocrinology.

Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.

H. Orskov, J. Christiansen, C. Binder, 1983, Acta endocrinologica.

Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

H. Orskov, S. Sherlock, G. Smith-Laing, 1980, Diabetologia.

Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex.

Jens Sandahl Christiansen, Claus Højbjerg Gravholt, H. Orskov, 2005, Diabetes.

Suppression of the night increase in serum TSH during development of ketosis in diabetic patients

K. Alberti, P. Laurberg, H. Orskov, 1981, Journal of endocrinological investigation.

Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient.

Jody T. Bruulsema, M S Patterson, L Heinemann, 1997, Optics letters.

Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study.

K. Alberti, H. Orskov, K. Hermansen, 1987, Acta endocrinologica.

A new principle for simplified and continuous counting of radioactive samples: enclosure between adhesive tapes.

H. Orskov, H. J. Gundersen, 1977, Scandinavian journal of clinical and laboratory investigation.

Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.

K. Alberti, D. Johnston, H. Orskov, 1984, Diabete & metabolisme.

Acetate suppresses growth hormone secretion in uremic patients: hemodialysis and acetate infusion experiments.

H. E. Hansen, K. Alberti, A. P. Hansen, 1982, Artificial Organs.

Normalisation of growth hormone hypersecretion in uraemic diabetics and non-diabetics. Studies with artificial pancreas and artificial kidney.

H. E. Hansen, K. Alberti, A. P. Hansen, 1979, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.

H. Orskov, P. Hardiman, J. Ginsburg, 1995, Human reproduction.

Effect of growth hormone dosing on ultimate weight and length of XO mice.

H. Orskov, K. Jørgensen, S. Jensen, 1989, Pharmacology & toxicology.

[Research or journalism].

H. Orskov, J. Djurhuus, 1991, Ugeskrift for laeger.

Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).

H. E. Hansen, K. Alberti, H. Orskov, 1987, The Journal of diabetic complications.

Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.

K. Alberti, H. Orskov, A. Flyvbjerg, 1987, Acta endocrinologica.

Effects of 2 wk of GH administration on 24-h indirect calorimetry in young, healthy, lean men.

A. Astrup, M. Kjaer, H. Orskov, 2005, American journal of physiology. Endocrinology and metabolism.

The glucose sensor. Some results and applications.

A. P. Hansen, H. Orskov, O. Schmitz, 2009, Acta medica Scandinavica. Supplementum.

Preliminary results with Sandostatin nasal powder in acromegalic patients.

A. Harris, H. Orskov, S. E. Christensen, 1992, Metabolism: Clinical and Experimental.